# Commission Implementing Regulation (EU) 2020/1147 of 31 July 2020 granting a Union authorisation for the single biocidal product ‘ClearKlens product based on IPA’ (Text with EEA relevance), Division 4.2.2: Use-specific risk mitigation measures

Extent: E+W+S+N.I.

Apply the product only in a sufficiently ventilated room. The minimum air change rates required are
8/h in laboratories,
60/h in pharmaceutical and cosmetics manufacturing facilities,
150/h in cleanrooms.
Do not use more than 18,4 mL product/m2.
The following personal risk mitigation measure can be applied for wiping disinfection unless it can be replaced by technical and/or organisational measures: Wear eye protection during handling of the product.

---
Source: https://www.legislation.gov.uk/eur/2020/1147/annex/division/4/division/4.2/division/4.2.2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2020-1147/annex/division-4/division-4.2/division-4.2.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.